{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:20:05Z","timestamp":1787437205652,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[1992,7,1]],"date-time":"1992-07-01T00:00:00Z","timestamp":709948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1992,7,1]],"date-time":"1992-07-01T00:00:00Z","timestamp":709948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1992,7]]},"DOI":"10.1136\/ard.51.7.885","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"885-888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis."],"prefix":"10.1016","volume":"51","author":[{"given":"H.J","family":"Haga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"D'Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Asherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.R","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.2.5091.265","article-title":"Giant cell granuloma of the respiratory tract (Wegener's granulomatosis)","volume":"ii:","author":"W, Walton E.","year":"1958","unstructured":"Walton E W. Giant cell granuloma of the respiratory tract (Wegener's granulomatosis). BMJ 1958; ii: 265-70.","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener's granulomatosis. Prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"S, Fauci A.; F, Haynes B.; P, Katz; M, Wolff S.","year":"1983","unstructured":"Fauci A S, Haynes B F, Katz P, Wolff S M. Wegener's granulomatosis. Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76-85.","journal-title":"Ann Intern Med"},{"key":"ref_3","first-page":"39","article-title":"Treatment of Wegener's granulomatosis with cyclophosphamide: an outcome analysis","volume":"(suppl):","author":"R, Weiner S.; E, Paulus H.","year":"1988","unstructured":"Weiner S R, Paulus H E. Treatment of Wegener's granulomatosis with cyclophosphamide: an outcome analysis. Arthritis Rheum 1988; 31 (suppl): 39.","journal-title":"Arthritis Rheum"},{"key":"ref_4","first-page":"614","article-title":"Controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"A, Austin H.; H, Klippel J.; E, Balow J.","year":"1986","unstructured":"Austin H A, Klippel J H, Balow J E, et al. Controlled trial of prednisone and cytotoxic drugs. N Engl Jf Med 1986; 314: 614-9.","journal-title":"N Engl Jf Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.7326\/0003-4819-106-1-79","article-title":"NIH conference: lupus nephritis","volume":"106","author":"E, Balow J.; A, Austin H.; T, George C.; T, Antonovych T.; D, Steinberg A.; H, Klippel J.","year":"1987","unstructured":"Balow J E, Austin H A, George C T, Antonovych T T, Steinberg A D, Klippel J H. NIH conference: lupus nephritis. Ann Intern Med 1987; 106: 79-94.","journal-title":"Ann Intern Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-89-5-660","article-title":"The spectrum of vasculitis. Clinical, pathologic, immunologic, and therapeutic considerations","volume":"89","author":"S, Fauci A.; F, Haynes B.; P, Katz","year":"1978","unstructured":"Fauci A S, Haynes B F, Katz P. The spectrum of vasculitis. Clinical, pathologic, immunologic, and therapeutic considerations. Ann Intern Med 1978; 89: 660-76.","journal-title":"Ann Intern Med"},{"key":"ref_7","first-page":"155","article-title":"The vasculitides. In: Major problems in internal medictne","author":"R, Cupps T.; S, Fauci A.","year":"1981","unstructured":"Cupps T R, Fauci A S. The vasculitides. In: Major problems in internal medictne. Philadelphia: Saunders, Vol. XXI. 1981: 155-72."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9343(84)90654-5","article-title":"Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis","volume":"76","author":"G, Scott D.; A, Bacon P.","year":"1984","unstructured":"Scott D G, Bacon P A. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am 7 Med 1984; 76: 377-84.","journal-title":"Am 7 Med"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0002-9343(79)90634-X","article-title":"Immunosuppressive and corticosteroid therapy of polyarteritis nodosa","volume":"67","author":"S, Leib E.; C, Restivo; E, Paulus H.","year":"1979","unstructured":"Leib E S, Restivo C, Paulus H E. Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am.7 Med 1979; 67: 941-7.","journal-title":"Am.7 Med"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM197908023010503","article-title":"Cyclophosphamide therapy of severe systemic necrotising vasculitis","volume":"301","author":"S, Fauci A.; P, Katz; F, Haynes B.; M, Wolff S.","year":"1979","unstructured":"Fauci A S, Katz P, Haynes B F, Wolff S M. Cyclophosphamide therapy of severe systemic necrotising vasculitis. N EnglJ Med 1979; 301: 235-8.","journal-title":"N EnglJ Med"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(89)92416-1","article-title":"Cyclophosphamide in severe polymyositis","volume":"i:","author":"Bombardieri, S.; V, Hughes G.R.; Neri, R.","year":"1989","unstructured":"Bombardieri S, Hughes G R V, Neri R, et al. Cyclophosphamide in severe polymyositis. Lancet 1989; i: 1138.","journal-title":"Lancet"},{"key":"ref_12","first-page":"1461","article-title":"Collaborative United Kingdom-Australian study of cancer in patients treated with immunosuppressive drugs","volume":"ii:","author":"J, Kinlen L.; R, Schell A.G.; J, Peto","year":"1979","unstructured":"Kinlen L J, Schell A G R, Peto J, et al. Collaborative United Kingdom-Australian study of cancer in patients treated with immunosuppressive drugs. BMJ 1979; ii: 1461-6.","journal-title":"BMJ"},{"key":"ref_13","first-page":"1271","article-title":"revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"M, Tan E.; S, Cohen A.; J, Fries","year":"1982","unstructured":"Tan E M, Cohen A S, Fries J, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.","journal-title":"The"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/096120339100100106","article-title":"Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis","volume":"1","author":"A, Houssiau F.; D, D.'Cruz; H-J, Haga; V, Hughes G.R.","year":"1991","unstructured":"Houssiau F A, D'Cruz D, Haga H-J, Hughes G R V. Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis. Lupus 1991; 1: 31-5.","journal-title":"Lupus"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJM198804213181604","article-title":"Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma","volume":"318","author":"Pederson-Bjergaard, J.; Ersboll, J.; L, Hansen V.","year":"1988","unstructured":"Pederson-Bjergaard J, Ersboll J, Hansen V L, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl j Med 1988; 318: 1028-32.","journal-title":"N Engl j Med"},{"key":"ref_16","first-page":"657","article-title":"Prevention of ifosphamide-induced urothelial toxicity in 2-mercaptoethane sulphonate sodium (l4esnum) in patients with advanced carcinoma","volume":"ii:","author":"M, Bryant B.; M, Jarman; T, Ford H.","year":"1980","unstructured":"Bryant B M, Jarman M, Ford H T, et al. Prevention of ifosphamide-induced urothelial toxicity in 2-mercaptoethane sulphonate sodium (l4esnum) in patients with advanced carcinoma. Lancet 1980; ii: 657-9.","journal-title":"Lancet"},{"key":"ref_17","first-page":"763","article-title":"Comparison of azathioprine, cyclophosphamide and gold in the treatment of rheumatoid arthritis","volume":"iii:","author":"F, Currey H.L.; J, Harris; M, Mason R.","year":"1974","unstructured":"Currey H L F, Harris J, Mason R M, et al. Comparison of azathioprine, cyclophosphamide and gold in the treatment of rheumatoid arthritis. BMJ 1974; iii: 763-6.","journal-title":"BMJ"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/anr.1780320108","article-title":"Infectious complications of cyclophosphamide treatment for vasculitis","volume":"32","author":"Bradley, J.; D, Brandt K.; P, Katz B.","year":"1989","unstructured":"Bradley J, Brandt K D, Katz B P. Infectious complications of cyclophosphamide treatment for vasculitis. Arthritis Rheum 1989; 32: 45-53.","journal-title":"Arthritis Rheum"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0049-0172(86)90020-X","article-title":"Cytotoxic drugs: their clinical application to the rheumatic diseases","volume":"15","author":"J, Clements P.; J, Davis","year":"1986","unstructured":"Clements P J, Davis J. Cytotoxic drugs: their clinical application to the rheumatic diseases. Semin Arthritis Rheum 1986; 15: 231-54.","journal-title":"Semin Arthritis Rheum"},{"key":"ref_20","first-page":"637","article-title":"Adrenal glucosteroids after twenty years: a review of their chemically relevant consequences","volume":"22","author":"S, David D.; H, Grieco M.; P, Jr, Cushman","year":"1970","unstructured":"David D S, Grieco M H, Cushman P Jr. Adrenal glucosteroids after twenty years: a review of their chemically relevant consequences. J Chronic Dis 1970; 22: 637-71 1.","journal-title":"J Chronic Dis"},{"key":"ref_21","first-page":"45","article-title":"Corticosteroids and infections","volume":"9","author":"H, Kass E.; M, Finland","year":"1958","unstructured":"Kass E H, Finland M. Corticosteroids and infections. Adv Intern Med 1958; 9: 45-80.","journal-title":"Adv Intern Med"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJM198806023182203","article-title":"Clinical and immunological effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus","volume":"318","author":"J, McCune W.; J, Golbus; W, Zeldes; P, Bohlke; R, Dunne; A, Fox D.","year":"1988","unstructured":"McCune W J, Golbus J, Zeldes W, Bohlke P, Dunne R, Fox D A. Clinical and immunological effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med 1988; 318: 1423-31.","journal-title":"N Engl J Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724035969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724035969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.51.7.885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T08:57:37Z","timestamp":1737449857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724035969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1992,7]]}},"alternative-id":["S0003496724035969"],"URL":"https:\/\/doi.org\/10.1136\/ard.51.7.885","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1992,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.51.7.885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1992 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}